St. Jude Medical Obtains Foreign Antitrust Clearance To Acquire Advanced Neuromodulation Systems

ST. PAUL, Minn.--(BUSINESS WIRE)--Nov. 11, 2005--St. Jude Medical, Inc. (NYSE:STJ) announced today that the German Federal Cartel Office confirmed that the acquisition of Advanced Neuromodulation Systems, Inc. (NASDAQ:ANSI) by St. Jude Medical may be completed. This approval, together with the previously announced expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, satisfies the antitrust approval condition set forth in the parties’ merger agreement. No other regulatory approvals are required for the merger.

MORE ON THIS TOPIC